New collaboration aims to research early mutations in rare blood disorder

New collaboration aims to research early mutations in rare blood disorder

Langerhans cell histiocytosis currently affects around one in 200,000 children in the UK

A new collaboration between Newcastle University, the Wellcome Sanger Institute (Sanger) and the SKAN Research Trust (SKAN) aims to investigate early…

[ad_2]

Source link

More From Author

Some sleep apnea patients see improvement with new breathing tool

Researchers pioneer noninvasive gene therapy for brain disorders

Researchers pioneer noninvasive gene therapy for brain disorders

Leave a Reply

Your email address will not be published. Required fields are marked *